DDC Antikörper (AA 390-440)
Kurzübersicht für DDC Antikörper (AA 390-440) (ABIN5689940)
Target
Alle DDC Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 390-440
-
Spezifität
- DDC antibody is human, mouse and rat reactive.
-
Aufreinigung
- DDC Antibody is affinity chromatography purified via peptide column.
-
Immunogen
-
DDC antibody was raised against a 14 amino acid peptide near the carboxy terminus of human DDC.
The immunogen is located within amino acids 390 - 440 of DDC . -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- DDC antibody can be used for detection of DDC by Western blot at 1 - 2 μ,g/mL.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- DDC Antibody is supplied in PBS containing 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- DDC antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
-
-
- DDC (Dopa Decarboxylase (Aromatic L-Amino Acid Decarboxylase) (DDC))
-
Andere Bezeichnung
- DDC
-
Hintergrund
- DOPA decarboxylase (DDC) belongs to the group II decarboxylase family of proteins (1). It is an important protein in the catecholamine biosynthesis pathway. DDC catalyzes the second reaction in the biosynthesis of catecholamines, trace amines and serotonin (1,2). It can form a homodimer and is expressed in the central nervous system (2). DDC can be used as markers for dopaminergic, noradrenergic and serotonergic neurons in a variety of applications including depression, schizophrenia, Parkinson's disease, neuroendocrine tumors and drug abuse (3,4). Defects in DDC gene may cause the autosomal recessive disorder AADC deficiency (4).
-
Molekulargewicht
-
Predicted: 53 kDa
Observed: 53 kDa -
Gen-ID
- 1644
-
NCBI Accession
- NP_000781
-
UniProt
- P20711
-
Pathways
- Dopaminergic Neurogenesis
Target
-